A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome

Completed · Phase 3 · Has a placebo group

Conditions studied: Dravet Syndrome

In brief

The primary purpose of this study is to evaluate the safety, tolerability, and efficacy of ZX008 (fenfluramine hydrochloride) when added to adjunctive antiepileptic stiripentol treatment in children and young adults with Dravet syndrome.

Key facts

Study ID
NCT02926898
Run by
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
People needed
87
Starts
2017-01-27
Expected to finish
2018-06-05
Last updated by the study team
2022-11-02

Who can join

Age: 2 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.